1.82850 EUR
0.0345
1.85%
Last update Dec 16, 9:55 PM CET
Main market
Day range
1.82550
1.87450
Previous close
1.86300
Open
1.84950
Access this stock data via API
Subscribe
ImmunityBio, Inc.
1.83
0.03
1.85%

Financials

Income statement

Fundamentals currency is USD
Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 27.3M 22.5M 14.1M 6.4M
Cost of revenue 150.8K 115.9K 49.4K 0
Gross profit 27.2M 22.4M 14.0M 6.4M
Operating expense
Research & development 43.7M 47.1M 41.1M 30.0M
Selling general and admin 30.9M 36.1M 27.8M 35.6M
Other operating expenses
Operating income -47.4M -60.8M -54.9M -59.1M
Non operating interest income
Income 657.9K 697.1K 443.2K 655.4K
Expense 23.5M 24.6M 24.6M 12.7M
Other income expense 12.9M 6.0M -31.6M 40.1M
Pretax income -57.4M -78.7M -110.7M -50.4M
Tax provision -29.8K 229.3K -199.4K 0
Net income -57.3M -78.9M -110.5M -50.4M
Basic EPS -0.1 -0.2 -0.1
Diluted EPS -0.1 -0.2 -0.1
Basic average shares 757.0M 727.1M 624.9M
Diluted average shares 757.0M 727.1M 626.0M
EBITDA -43.5M -56.0M -87.5M -37.2M
Net income from continuing op. -57.3M -78.9M -110.5M -50.4M
Minority interests 17.9K 16.2K 17.0K 14.5K
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 7 hours 48 minutes

14:11
00:00
08:00
22:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 22:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).